Evidence map›Paper›PMID 27922604›Full record

ArticleMolecular psychiatry2017

Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.

H Yu, H Yan, J Li, Z Li, X Zhang, Y Ma, L Mei, C Liu, L Cai, Q Wang and 22 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Review
  13. Genetic implication of GABAFrontiers in pharmacology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

H YuTsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0001-6549-3713
H YanDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.ORCID 0000-0003-0376-9037
J LiDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Z LiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
X ZhangBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0003-0262-7854
Y MaDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
L MeiDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
C LiuDepartment of Psychiatry, the University of Melbourne, Parkville, VIC, Australia.
L CaiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
Q WangMental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
F ZhangDepartment of Clinical Psychology, Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China.
N IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.
M IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan.
L WangDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
T LuDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
Chinese Schizophrenia Collaboration Group
M LiDepartment of Rheumatology and Immunology, Shanghai Changzheng Hospital, the Second Military Medical University, Shanghai, China.ORCID 0000-0002-8197-6552
H XuDepartment of Rheumatology and Immunology, Shanghai Changzheng Hospital, the Second Military Medical University, Shanghai, China.
X WuDepartment of Rheumatology and Immunology, Shanghai Changzheng Hospital, the Second Military Medical University, Shanghai, China.
B LiuBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
J YangTianjin Anding Hospital, Tianjin, China.
K LiHebei Mental Health Center, Baoding, Hebei, China.
L LvThe Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
X MaBeijing Anding Hospital, Capital Medical University, Beijing, China.
C WangBeijing Anding Hospital, Capital Medical University, Beijing, China.
L LiThe Second Xiangya Hospital of Central South University, Changsha, China.
F YangBeijing HuiLongGuan Hospital, Peking University, Beijing, China.
T JiangBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0002-0607-3775
Y ShiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
T LiMental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
D ZhangDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.
W YueDepartment of Biochemistry, Institute of Mental Health, The Sixth Hospital, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many schizophrenia susceptibility loci have been identified through genome-wide association studies (GWASs) in European populations. However, until recently, schizophrenia GWASs in non-European populations were limited to small sample sizes and have yielded few loci associated with schizophrenia. To identify genetic risk variations for schizophrenia in the Han Chinese population, we performed a two-stage GWAS of schizophrenia comprising 4384 cases and 5770 controls, followed by independent replications of 13 single-nucleotide polymorphisms in an additional 4339 schizophrenia cases and 7043 controls of Han Chinese ancestry. Furthermore, we conducted additional analyses based on the results in the discovery stage. The combined analysis confirmed evidence of genome-wide significant associations in the Han Chinese population for three loci, at 2p16.1 (rs1051061, in an exon of VRK2, P=1.14 × 10

Indexed as

Asian PeopleCase-Control StudiesChinaEthnicityGenetic LociGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansMethyltransferasesOdds RatioPolymorphism, Single NucleotideProtein Serine-Threonine KinasesReceptors, GABA-BRisk FactorsSchizophreniaAS3MT protein, humanMethyltransferasesProtein Serine-Threonine KinasesReceptors, GABA-BVRK2 protein, human

Identifiers

PMID27922604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.